Immunohistochemistry (IHC) is used to detect the deletion of FH expression in tumor cells to diagnose FH-deficient renal cell carcinoma, which has been proved to be closely related to the inactivation mutation of the FH gene (Smith et al., 2016). The gene discussed is FH; the disease is hereditary clear cell renal cell carcinoma.